The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

AC1NS422     6-[(4E)-4-[(2E)-2-(5-hydroxy- 2-methylidene...

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of 25-Hydroxycholecalciferol


Psychiatry related information on 25-Hydroxycholecalciferol


High impact information on 25-Hydroxycholecalciferol


Chemical compound and disease context of 25-Hydroxycholecalciferol


Biological context of 25-Hydroxycholecalciferol


Anatomical context of 25-Hydroxycholecalciferol


Associations of 25-Hydroxycholecalciferol with other chemical compounds


Gene context of 25-Hydroxycholecalciferol


Analytical, diagnostic and therapeutic context of 25-Hydroxycholecalciferol


  1. The pathophysiology of altered calcium metabolism in rhabdomyolysis-induced acute renal failure. Interactions of parathyroid hormone, 25-hydroxycholecalciferol, and 1,25-dihydroxycholecalciferol. Llach, F., Felsenfeld, A.J., Haussler, M.R. N. Engl. J. Med. (1981) [Pubmed]
  2. 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol: conversion impaired by systemic metabolic acidosis. Lee, S.W., Russell, J., Avioli, L.V. Science (1977) [Pubmed]
  3. Phosphate control and 25-hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog. Rutherford, W.E., Bordier, P., Marie, P., Hruska, K., Harter, H., Greenwalt, A., Blondin, J., Haddad, J., Bricker, N., Slatopolsky, E. J. Clin. Invest. (1977) [Pubmed]
  4. Metabolites of vitamin D in human vitamin-D deficiency: effect of vitamin D3 or 1,25-dihydroxycholecalciferol. Papapoulos, S.E., Clemens, T.L., Fraher, L.J., Gleed, J., O'Riordan, J.L. Lancet (1980) [Pubmed]
  5. Letter: 25-Hydroxycholecalciferol in chronic renal failure. Lund, B., Sorensen, O.H., Nielsen, S.P., Munck, O., Bärenholdt, O., Petersen, K. Lancet (1975) [Pubmed]
  6. Double-blind, controlled calcium supplementation and bone mineral accretion in children accustomed to a low-calcium diet. Lee, W.T., Leung, S.S., Wang, S.H., Xu, Y.C., Zeng, W.P., Lau, J., Oppenheimer, S.J., Cheng, J.C. Am. J. Clin. Nutr. (1994) [Pubmed]
  7. Vitamin D status among patients with fractured neck of femur in Hong Kong. Pun, K.K., Wong, F.H., Wang, C., Lau, P., Ho, P.W., Pun, W.K., Chow, S.P., Cheng, C.L., Leong, J.C., Young, R.T. Bone (1990) [Pubmed]
  8. Calcifediol in chronic renal insufficiency. Skeletal response. Teitelbaum, S.L., Bone, J.M., Stein, P.M., Gilden, J.J., Bates, M., Boisseau, V.C., Avioli, L.V. JAMA (1976) [Pubmed]
  9. Inhibition of parathyroid hormone secretion by 25-hydroxycholecalciferol and 24,25-dihydroxycholecalciferol in the dog. Canterbury, J.M., Lerman, S., Claflin, A.J., Henry, H., Norman, A., Reiss, E. J. Clin. Invest. (1978) [Pubmed]
  10. 25-hydroxycholecalciferol-enhanced bone maturation in the parathyroprivic state. Russell, J.E., Avioli, L.V. J. Clin. Invest. (1975) [Pubmed]
  11. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Wilkinson, R.J., Llewelyn, M., Toossi, Z., Patel, P., Pasvol, G., Lalvani, A., Wright, D., Latif, M., Davidson, R.N. Lancet (2000) [Pubmed]
  12. Experimental renal osteodystrophy. The response to 25-hydroxycholecalciferol and dicholomethylene diphosphate therapy. Russell, J.E., Termine, J.D., Avioli, L.V. J. Clin. Invest. (1975) [Pubmed]
  13. Effect of phenytoin on bone and vitamin D metabolism. Bell, R.D., Pak, C.Y., Zerwekh, J., Barilla, D.E., Vasko, M. Ann. Neurol. (1979) [Pubmed]
  14. Intestinal absorption of cholecalciferol and 25-hydroxycholecalciferol in patients with both Crohn's disease and intestinal resection. Leichtmann, G.A., Bengoa, J.M., Bolt, M.J., Sitrin, M.D. Am. J. Clin. Nutr. (1991) [Pubmed]
  15. Aluminum localization in bone from hemodialyzed patients: relationship to matrix mineralization. Cournot-Witmer, G., Zingraff, J., Plachot, J.J., Escaig, F., Lefèvre, R., Boumati, P., Bourdeau, A., Garabédian, M., Galle, P., Bourdon, R., Drüeke, T., Balsan, S. Kidney Int. (1981) [Pubmed]
  16. Exogenous 25-hydroxycholecalciferol does not attenuate salt-induced hypertension. Thierry-Palmer, M., Tewolde, T.K., Wang, M., Carlyle, K.S., Forté, C., Bayorh, M.A., Emmett, N.L., Williams, E.F. J. Steroid Biochem. Mol. Biol. (1998) [Pubmed]
  17. Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment. Matloff, D.S., Kaplan, M.M., Neer, R.M., Goldberg, M.J., Bitman, W., Wolfe, H.J. Gastroenterology (1982) [Pubmed]
  18. Widespread, specific binding of 25-hydroxycholecalciferol in rat tissues. Haddad, J.G., Birge, S.J. J. Biol. Chem. (1975) [Pubmed]
  19. Acute administration of 25-hydroxycholecalciferol in man. Haddad, J.G., Rojanasathit, S. J. Clin. Endocrinol. Metab. (1976) [Pubmed]
  20. Vitamin D status in the elderly: seasonal substrate deficiency causes 1,25-dihydroxycholecalciferol deficiency. Bouillon, R.A., Auwerx, J.H., Lissens, W.D., Pelemans, W.K. Am. J. Clin. Nutr. (1987) [Pubmed]
  21. 1,25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation. Pillai, S., Bikle, D.D., Elias, P.M. J. Biol. Chem. (1988) [Pubmed]
  22. 25 Hydroxycholecalciferol levels in Beduin women in labor and in cord blood of their infants. Biale, Y., Shany, S., Levi, M., Shainkin-Kestenbaum, R., Berlyne, G.M. Am. J. Clin. Nutr. (1979) [Pubmed]
  23. In vitro metabolism of 25-hydroxycholecalciferol by isolated cells from human decidua. Delvin, E.E., Arabian, A., Glorieux, F.H., Mamer, O.A. J. Clin. Endocrinol. Metab. (1985) [Pubmed]
  24. Insulin-treatment of diabetic rats: effects on duodenal calcium absorption. Schneider, L.E., Nowosielski, L.M., Schedl, H.P. Endocrinology (1977) [Pubmed]
  25. Characterization of a monoclonal antibody to human serum vitamin D binding protein (Gc globulin): recognition of an epitope hidden in membranes of circulating monocytes. McLeod, J.F., Kowalski, M.A., Haddad, J.G. Endocrinology (1986) [Pubmed]
  26. Effects of vitamin D3 metabolites on cytosolic free calcium in confluent mouse osteoblasts. Lieberherr, M. J. Biol. Chem. (1987) [Pubmed]
  27. Human serum binding capacity and affinity for 25-hydroxyergocalciferol and 25-hydroxycholecalciferol. Haddad, J.G., Hillman, L., Rojanasathit, S. J. Clin. Endocrinol. Metab. (1976) [Pubmed]
  28. Amobarbital interactions with 25-hydroxycholecalciferol: effects on the extraction, quantification, and competitive protein binding in vitro. Majors, S.H., Howe, J.C., Beecher, G.R. J. Clin. Endocrinol. Metab. (1985) [Pubmed]
  29. Competition by 24,25-dihydroxycholecalciferol in the competitive protein binding radioassay of 25-hydroxycalciferol. Haddad, J.G., Min, C., Walgate, J., Hahn, T. J. Clin. Endocrinol. Metab. (1976) [Pubmed]
  30. Rifampicin and vitamin D metabolism. Brodie, M.J., Boobis, A.R., Dollery, C.T., Hillyard, C.J., Brown, D.J., MacIntyre, I., Park, B.K. Clin. Pharmacol. Ther. (1980) [Pubmed]
  31. Megalin-mediated endocytosis of vitamin d binding protein correlates with 25-hydroxycholecalciferol actions in human mammary cells. Rowling, M.J., Kemmis, C.M., Taffany, D.A., Welsh, J. J. Nutr. (2006) [Pubmed]
  32. Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25-hydroxyvitamin D-3, the major circulating form of vitamin D-3. Kemmis, C.M., Salvador, S.M., Smith, K.M., Welsh, J. J. Nutr. (2006) [Pubmed]
  33. Value of assessing parathyroid hormone-like activity in a case of extreme hypercalcaemia. Ranganath, L., Jamal, H., Jones, L., Goddard, P.F. J. Clin. Pathol. (1998) [Pubmed]
  34. 1,25-dihydroxycholecalciferol stimulates ICAM-1 expression of human alveolar macrophages in healthy controls and patients with sarcoidosis. Braun, J., Dinkelacker, C., Bohnet, S., Kreft, B., Dalhoff, K. Lung (1999) [Pubmed]
  35. Leiomyoblastoma associated with intractable hypercalcemia and elevated 1,25-dihydroxycholecalciferol levels. Treatment by hepatic enzyme induction. Maislos, M., Sobel, R., Shany, S. Arch. Intern. Med. (1985) [Pubmed]
  36. Histological renal osteodystrophy, and 25 hydroxycholecalciferol and aluminum levels in patients on continuous ambulatory peritoneal dialysis. Gokal, R., Ramos, J.M., Ellis, H.A., Parkinson, I., Sweetman, V., Dewar, J., Ward, M.K., Kerr, D.N. Kidney Int. (1983) [Pubmed]
  37. Vitamin D metabolism in nephrotic rats. Chan, Y.L., Mason, R.S., Parmentier, M., Savdie, E., Lissner, D., Posen, S. Kidney Int. (1983) [Pubmed]
  38. Interaction of the vitamin D-binding protein (group-specific component) and its ligand 25-hydroxy-vitamin D3: binding differences of the various genetic types disclosed by isoelectric focusing. Braun, A., Brandhofer, A., Cleve, H. Electrophoresis (1990) [Pubmed]
  39. Purification and characterization of the ferredoxin component of 25-hydroxycholecalciferol 1 alpha-hydroxylase. Kulkoski, J.A., Ghazarian, J.G. Biochem. J. (1979) [Pubmed]
WikiGenes - Universities